| We are pleased to inform you that with effect from July 4th, 2022, our head office has been relocated to the following new location. Our current address in contracts and related documents is to be replaced by the following : |
|
| •New Address : | Tokyo Sumitomo Twin Building East, 2-27-1, Shinkawa, Chuo-ku, Tokyo 104-0033 Japan |
| •New Phone number : | +81-(0)3-5544-8133 |
| Planet Pharma Solutions,Inc. CEO: Hidemichi Fukasawa |
|
We have established a Privacy Policy.
Thank you for using our PharmaDoc products.
We have established a Privacy Policy divided into the following chapters.
We have established a Privacy Policy divided into the following chapters.
- Policy on the Protection of Personal Information
- Purpose of Use of Personal Information
- Provision of Personal Information to Third Parties
- Use in the Sharing of Personal Information
Use in sharing with M3, Inc. and the companies of the M3 Group - Policy on Cookies
About cookies
Cookie preferences
Things that PPS uses cookies for - Disclosure of Personal Information
- Contact Us
For details, please see our Privacy Policy
Obtained ISO27001:2013 and ISO27017:2015 recertification.
This is to report that we have undergone an external audit and have received
recertification for ISO’s information security management system standard
ISO27001:2013 and ISMS cloud security management system standard
ISO27017:2015.
Date of recertification: October 18, 2021
Expiration date: October 17, 2024
We are pleased to announce that we are now under the umbrella of Mediscience Planning Inc.
| We are pleased to announce that we are now under the umbrella of Mediscience Planning Inc. The executive officers shown below have been appointed and assumed their duties on October 1. Our new organization will make it possible to provide stable support for PharmaDoc products over the long term. We will wholeheartedly devote ourselves to expanding our business, so please continue to provide us with guidance and encouragement. |
|
| Planet Pharma Solutions,Inc. CEO: Hidemichi Fukasawa |
|
| List of Executive Officers | |
| CEO: | Hidemichi Fukasawa |
| Director: | Akinori Urae (Chairman and Chief Executive Officer of Mediscience Planning, MD, PhD) |
| Director: | Satoshi Yamazaki |
We are delighted to announce a partnership with Generis.
We are delighted to announce a partnership with Generis.
For more details, see the website below.
We have developed complementary explanatory materials regarding the ICC profile.
To our customers:
Thank you for your continued support.
A requirement called “Use the ICC profile for color matching” was added to the specification requirements of eCTD4.0’s leaf file.
We have developed complementary explanatory materials explaining what the ICC profile is, and how to address it.
If you would like to review these explanatory materials, please contact our representative Fukasawa (fukasawa@pp-solutions.jp).
We got a certificate of ISO27001:2013, a standard for information security.
We got a certificate of ISO27001:2013, a standard for information security.
We got a certificate of ISO27017:2015 to our cloud services.
We got a certificate of ISO27017:2015 to our cloud services.
We uploaded an introduction video of PharmaDoc Redact
We uploaded an introduction video of PharmaDoc Redact, which is a tool that streamlines the task of creating documents for publication, on our website.
We adapted our quality management system to world standard ISO9001:2015
We adapted our quality management system to world standard ISO9001:2015 and revised the certification for ” development and support of software products developed in-house and regulatory affairs for medicines and medical equipment”.
Certification criteria: ISO 9001:2015 , JIS Q 9001:2015
Certification scope: development and support of software products developed in-house and regulatory affairs for medicines and medical equipment.
Certificate No: 4000775
Revision Date: December 14, 2017
